Karyopharm Therapeutics (NASDAQ:KPTI) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Karyopharm Therapeutics (KPTI) operate in?

Karyopharm Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Karyopharm Therapeutics Stock (NASDAQ: KPTI) stock price, news, charts, stock research, profile.

Open	$0.77
Close	-
Volume / Avg.	439.49K / 745.52K
Day Range	$0.77 - $0.87
52 Wk Range	0.62 - 1.95
Market Cap	$106.96M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	14.4%
Days to Cover	18.59

Recent News

Down -12.14% in 4 Weeks, Here's Why Karyopharm Therapeutics Looks Ripe for a Turnaround

Karyopharm Therapeutics (NASDAQ: KPTI) has been beaten down lately with too much selling pressure.

Zacks

Karyopharm's Selinexor Shows Progression-Free Survival of 27.4 Months In Endometrial Cancer With Certain Mutation

Karyopharm Therapeutics Inc (NASDAQ: KPTI) announced the presentation of updated exploratory subgroup analyses from the SIENDO study in patients with advanced or recurrent TP53 wild-type endometrial cancer at the virtual American Society of Clinical

Vandana Singh

Why Are Karyopharm Therapeutics Shares Gaining Today?

Karyopharm Therapeutics Inc (NASDAQ: KPTI) shares are trading higher after the FDA granted Fast Track Designation to the development program of selinexor for myelofibrosis, including primary myelofibrosis, post-essential thrombocythemia myelofibrosis, and post-

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Aug

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.77
Close	-
Volume / Avg.	439.49K / 745.52K
Day Range	$0.77 - $0.87
52 Wk Range	0.62 - 1.95
Market Cap	$106.96M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	14.4%
Days to Cover	18.59

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Karyopharm Therapeutics (KPTI) stock?

You can purchase shares of Karyopharm Therapeutics (NASDAQ:KPTI) through any online brokerage.

View our list of the best stock brokerages

Who are Karyopharm Therapeutics (KPTI) competitors?

Other companies in Karyopharm Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Cabaletta Bio (NASDAQ:CABA), Monopar Therapeutics (NASDAQ:MNPR), Inovio Pharmaceuticals (NASDAQ:INO) and Genelux (NASDAQ:GNLX).

What is the forecast, or price target, for Karyopharm Therapeutics (KPTI) stock?

Karyopharm Therapeutics has a consensus price target of $6.30.

What is the current price for Karyopharm Therapeutics (KPTI)?

The stock price for Karyopharm Therapeutics (NASDAQ: KPTI) is $0.8535 last updated November 22, 2024 at 3:05 PM EST.

Does Karyopharm Therapeutics (KPTI) pay a dividend?

There are no upcoming dividends for Karyopharm Therapeutics.

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

Karyopharm Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.

Is Karyopharm Therapeutics (KPTI) going to split?

There is no upcoming split for Karyopharm Therapeutics.

What sector and industry does Karyopharm Therapeutics (KPTI) operate in?

Karyopharm Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Karyopharm Therapeutics

Karyopharm Therapeutics (KPTI) Forecast

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Quotes, Forecast and News Summary

Recent News

Financials

Analyst Trends and Forecast

Analyst Rating and Forecast

Compare

FAQ

How do I buy Karyopharm Therapeutics (KPTI) stock?

Who are Karyopharm Therapeutics (KPTI) competitors?

What is the forecast, or price target, for Karyopharm Therapeutics (KPTI) stock?

What is the current price for Karyopharm Therapeutics (KPTI)?

Does Karyopharm Therapeutics (KPTI) pay a dividend?

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

Is Karyopharm Therapeutics (KPTI) going to split?

What sector and industry does Karyopharm Therapeutics (KPTI) operate in?

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga